Zurich Cantonal Bank
UTMD icon

Zurich Cantonal Bank’s Utah Medical Products UTMD Stock Holding History

Zurich Cantonal Bank’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-1,464
Closed -$91K – 2566
2017
Q1 		$91K Buy
+1,464
New +$92.1K ﹤0.01% 1422
2016
Q4 		– Sell
-976
Closed -$58K – 2576
2016
Q3 		$58K Sell
976
-124
-11% -$7.89K ﹤0.01% 1556
2016
Q2 		$69K Buy
+1,100
New +$70.9K ﹤0.01% 1343

Other funds holding UTMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Zurich Cantonal Bank's UTMD Position: Q2 2017 in Review

Zurich Cantonal Bank sold out of Utah Medical Products (UTMD) in Q2 2017, closing a stake of 1,464 shares — an estimated $91K sold.

Zurich Cantonal Bank first reported a position in UTMD in Q2 2016 and held it in 3 quarters. The position peaked at $91K in Q1 2017. 76 funds tracked by Wall St. Rank hold UTMD as of Q2 2017.

  • Zurich Cantonal Bank reported no remaining Utah Medical Products position as of Q2 2017 after selling out during the quarter.
  • Zurich Cantonal Bank sold 1,464 Utah Medical Products shares in Q2 2017, an estimated $91K.
  • Zurich Cantonal Bank first reported a position in Utah Medical Products in Q2 2016 and held it in 3 quarters.
  • Zurich Cantonal Bank's Utah Medical Products position peaked at $91K in Q1 2017.
  • 76 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2017.

Based on Zurich Cantonal Bank's 13F filing for Q2 2017, filed 8 Aug 2017.